Abatacept Treatment in Polymyositis and Dermatomyositis

Trial Profile

Abatacept Treatment in Polymyositis and Dermatomyositis

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Oct 2017

At a glance

  • Drugs Abatacept (Primary)
  • Indications Dermatomyositis; Polymyositis
  • Focus Therapeutic Use
  • Acronyms ARTEMIS
  • Most Recent Events

    • 09 Oct 2017 Results published in the Annals of the Rheumatic Diseases Journal.
    • 27 Jul 2015 New trial record
    • 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top